1-20 of 30
Anne W. Beaven
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 Trial of CD30-Directed, CCR4 Co-Expressing Chimeric Antigen Receptor T-Cells in Patients with CD30 + Cutaneous T-Cell Lymphomas Refractory to Brentuximab Vedotin

Daniel K Reef, Catherine Joyce Arago Cheng, Caroline Babinec, Kelly Hoye, John West, J. Kaitlin Morrison, Faith Brianne Buchanan, Ashley Zanter, Angela Denise Spruill, Kimberly A. Kasow, Anastasia Ivanova, Edith Bowers, Jonathan Serody, Barbara Savoldo, Gianpietro Dotti, Natalie Grover, Anne W Beaven
Journal: Blood
Blood (2024) 144 (Supplement 1): 3468.
https://doi.org/10.1182/blood-2024-201799
Published: 2024
Journal Articles

Survival and Therapeutic Outcomes in T-Cell Prolymphocytic Leukemia (T-PLL): A Collaborative Multi-Center Study Cohort

Zachary Braunstein, Eric McLaughlin, Prasanth Lingamaneni, Stefan K. Barta, Miao Cao, Tiffany Chang, Nivetha Ganesan, Binh Luu, Neha Mehta-Shah, Tanaya Shree, Marcus P. Watkins, Jasmine Zain, Pamela B. Allen, Darina Paulino, Brittany Adams, Jie Wang, Amber Feng, Enrica Marchi, Nathan Roberts, Ryan A. Wilcox, Marc Gabriel Gutierrez, Zachary AK Frosch, Tammarah Sklarz, Tarsheen Sethi, Francine M. Foss, Anne W Beaven, Bradley M. Haverkos, Rachel Treitman, Patrick Stevens, Anjali Mishra, Robert Stuver, Paul J Hampel, Jonathan E. Brammer
Journal: Blood
Blood (2024) 144 (Supplement 1): 982.
https://doi.org/10.1182/blood-2024-194242
Published: 2024
Journal Articles

CD30.CAR-T Cells Co-Expressing the CCR4 Chemokine Receptor in Relapsed/Refractory Hodgkin Lymphoma

Natalie Grover, Dominic Moore, Anastasia Ivanova, Anne W Beaven, Christopher Dittus, Catherine Joyce Arago Cheng, Kelly Hoye, Caroline Babinec, Faith Brianne Buchanan, Angela Denise Spruill, Ashley Zanter, John West, J. Kaitlin Morrison, Paul Armistead, Kimberly A. Kasow, Jonathan Serody, Gianpietro Dotti, Barbara Savoldo
Journal: Blood
Blood (2024) 144 (Supplement 1): 919.
https://doi.org/10.1182/blood-2024-200932
Published: 2024
Journal Articles

Trial in Progress - Alliance A052101: A Randomized Phase 3 Trial of Continuous Vs. Intermittent Maintenance Therapy with Zanubrutinib As Upfront Treatment in Older Patients with Mantle Cell Lymphoma

Anne W Beaven, Susan M. Geyer, Jonathon B. Cohen, Tycel Phillips, Travis Dockter, Priyanka A. Pophali, Gita Thanarajasingam, Gina L. Mazza, Alvaro J Alencar, Shira N. Dinner, Eric D. Hsi, Meng Welliver, Daniel Nikcevich, Brad S. Kahl, Jonathan W. Friedberg, Nancy L. Bartlett, John P. Leonard
Journal: Blood
Blood (2024) 144 (Supplement 1): 1661.3.
https://doi.org/10.1182/blood-2024-207372
Published: 2024
Journal Articles

T-cell lymphoma: the CAR-T revolution is coming

Clinical Trials & Observations
Natalie S. Grover, Anne W. Beaven
Journal: Blood
Blood (2024) 143 (13): 1201–1202.
https://doi.org/10.1182/blood.2023023443
Published: 2024
Journal Articles

Clinical Activity of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed Hodgkin Lymphoma

Timothy J. Voorhees, Anne W. Beaven, Christopher Dittus, George E Hucks, J. Kaitlin Morrison, Catherine Joyce Arago Cheng, Tammy Cavallo, Steven I. Park, Gianpietro Dotti, Jonathan S. Serody, Barbara Savoldo, Natalie S. Grover
Journal: Blood
Blood (2022) 140 (Supplement 1): 12723–12724.
https://doi.org/10.1182/blood-2022-156660
Published: 2022
Journal Articles

Differences in Progression and Survival Among Black Patients with Mycosis Fungoides and Sézary Syndrome: A Multicenter Retrospective Analysis at Large Urban Medical Centers

Pamela B. Allen, Subir Goyal, Swaminathan P. Iyer, Sai Talluru, Auris Huen, Irl Brian Greenwell, Jane Scribner, Shel Speegle, Tim Niyogusaba, Sunil Rangarajan, Amitkumar Mehta, Colin B. O'Leary, Anne W. Beaven, Jeffrey M. Switchenko, Amy Ayers, Safiyyah Bhatti, Shalini Krishnasamy, Pierluigi Porcu, Tarsheen Sethi, Francine M. Foss, Mary Jo Lechowicz, Sima Rozati
Journal: Blood
Blood (2022) 140 (Supplement 1): 9431–9433.
https://doi.org/10.1182/blood-2022-170921
Published: 2022
Journal Articles

A Pilot Study Evaluating Acalabrutinib for the Treatment of Relapsed/Refractory Primary and Secondary Central Nervous System Lymphomas

Christopher Dittus, Roy Ervin Strowd III, Kelly Hoye, Xianming Tan, Jordan Miller, Celeste Bello, Amir Khandani, Anne W. Beaven
Journal: Blood
Blood (2022) 140 (Supplement 1): 6616–6617.
https://doi.org/10.1182/blood-2022-165139
Published: 2022
Journal Articles

CD30-Directed Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Hodgkin Lymphoma and Non-Hodgkin Lymphoma in Pediatric Patients

George E. Hucks, Jr., Barbara Savoldo, Gianpietro Dotti, Catherine Joyce Arago Cheng, Caroline Babinec, Kimberly A. Kasow, Michael Winstead, Arpita Patel, Cammie Presler, Natalie S Grover, J. Kaitlin Morrison, Anne W. Beaven, Marcie L. Riches, Thomas C. Shea, Jonathan S. Serody
Journal: Blood
Blood (2021) 138 (Supplement 1): 2829.
https://doi.org/10.1182/blood-2021-153968
Published: 2021
Journal Articles

CD30-Directed CAR-T Cells Co-Expressing CCR4 in Relapsed/Refractory Hodgkin Lymphoma and CD30+ Cutaneous T Cell Lymphoma

Natalie S Grover, Anastasia Ivanova, Dominic T. Moore, Catherine Joyce Arago Cheng, Caroline Babinec, John West, Tammy Cavallo, J. Kaitlin Morrison, Faith Brianne Buchanan, Edith Bowers, Christopher Dittus, Anne W. Beaven, Gianpietro Dotti, Jonathan S. Serody, Barbara Savoldo
Journal: Blood
Blood (2021) 138 (Supplement 1): 742.
https://doi.org/10.1182/blood-2021-148102
Published: 2021
Journal Articles

S1918: A Phase II/III Randomized Study of R-Minichop with or without Oral Azacitidine (CC-486) in Participants Age 75 Years or Older with Newly Diagnosed Diffuse Large B Cell Lymphoma, Grade IIIb Follicular Lymphoma, Transformed Lymphoma, and High-Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements

Elizabeth A Brem, Hongli Li, Anne W. Beaven, Paolo F. Caimi, Leandro Cerchietti, Ash A. Alizadeh, Rebecca L. Olin, Norah Lynn Henry, Hildy Dilon, Richard F. Little, Cara Laubach, Michael L. Leblanc, Jonathan W. Friedberg, Sonali M. Smith
Journal: Blood
Blood (2021) 138 (Supplement 1): 3565.
https://doi.org/10.1182/blood-2021-148193
Published: 2021
Journal Articles

A Multicenter, Real World Analysis of Primary Central Nervous System Lymphoma in Those with and without Human Immunodeficiency Virus

Christopher Dittus, Natalie S Grover, Tarsheen Sethi, Jonathon B. Cohen, Alfredo Voloschin, Janhvi Rabadey, Xianming Tan, Anne W. Beaven, Steven I. Park
Journal: Blood
Blood (2021) 138 (Supplement 1): 1457.
https://doi.org/10.1182/blood-2021-145133
Published: 2021
Journal Articles

Frontline Bendamustine and Rituximab in Extranodal Marginal Zone Lymphoma: An International Analysis

Juan Pablo Alderuccio, MD, Anne W. Beaven, MD, Geoffrey Shouse, DO, PhD, Narendranath Epperla, MDMS, Alexandra Stefanovic, MD, Pallawi Torka, MD, Jorge J. Castillo, MD, Lisa Argnani, Timothy J Voorhees, MD, Ash B Alpert, MD MFA, Sayan Chowdhury, PhD, Isildinha M. Reis, PhD, Wei Zhao, MD MS, Dali Edwards, Peter Martin, FRCPC, MD MS, Manali Kamdar, MD, Alex F. Herrera, MD, Jonathan W. Friedberg, MD MSSc, Pier Luigi Zinzani, MD, Izidore S. Lossos, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-137620
Published: 2020
Journal Articles

Successful Treatment of Mature T-Cell Lymphoma with Allogeneic Stem Cell Transplantation: The Largest Multicenter Retrospective Analysis

Neha Mehta-Shah, MD, Ajitha Kommalapati, MD, Stephanie Teja, MD, Amanda F Cashen, MD, Parastoo B. Dahi, MD, Craig S. Sauter, MD, Alison J. Moskowitz, MD, Eric D Jacobsen, MD, Basem M. William, MDMRCP, Michael Ozga, MD, Stefan K. Barta, MDMRCP,MS, Alison W. Loren, MD, Steven Bair, MD, Pamela B. Allen, MD MSc, Shahana Sulaiman, Kevin Song, MD, Musa Alzahrani, MBBS, MHSc, Jia Ruan, MD PhD, Koen van Besien, MD PhD, Madhav Seshadri, MD, Matthew McKinney, Anne W. Beaven, MD, Bradley Haverkos, MD MPH, MS, Adam Starr, MD, Onder Alpdogan, MD, Pierluigi Porcu, MD, Francine M. Foss, MD, Yu Tao, MD, Steven M. Horwitz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–36.
https://doi.org/10.1182/blood-2020-138542
Published: 2020
Journal Articles

Short Course of Bendamustine and Rituximab Followed By 90Y-Ibritumomab Tiuxetan in Patients with Chemotherapy-Naive Follicular Lymphoma (FOL-BRITe): Final Report of Response Rates and Progression Free Survival

Cristiana A Costa, DO, Bassem I Zaki, MD, Stephanie P Yen, MD, Eric S Winer, MD, Helen Ryan, MD, Darcie Findley, Sara R Metzler, RN, Lynn Shaw, RN, Annie Tsui, RN, Todd A MacKenzie, PhD, Anne W Beaven, MD, Frederick Lansigan, MD
Journal: Blood
Blood (2016) 128 (22): 1793.
https://doi.org/10.1182/blood.V128.22.1793.1793
Published: 2016
Journal Articles

Safety and Preliminary Efficacy Results of a Phase I First-in-Human Study of the Novel Notch-1 Targeting Antibody Brontictuzumab (OMP-52M51) Administered Intravenously to Patients with Hematologic Malignancies

Carla Casulo, MD, Jia Ruan, MD PhD, Nam H. Dang, MD PhD, Lia Gore, MD, Catherine Diefenbach, MD, Anne W Beaven, MD, Januario E. Castro, MD, Pierluigi Porcu, MD, Leonardo Faoro, MD, Jakob Dupont, MD, Ann Kapoun, PhD, Min Wang, PhD, Kristin McGuire, Ian W. Flinn, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5108.
https://doi.org/10.1182/blood.V128.22.5108.5108
Published: 2016
Journal Articles

Phase I Dose-Escalation Study of Cpi-613, in Combination with Bendamustine, in Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

Zanetta S. Lamar, MD, Scott Isom, MS, Rakhee Vaidya, MD, Anne W Beaven, MD, Zachariah A. McIver, DO
Journal: Blood
Blood (2016) 128 (22): 4163.
https://doi.org/10.1182/blood.V128.22.4163.4163
Published: 2016
Journal Articles

Safe and Effective Treatment of Patients with Peripheral T-Cell Lymphoma (PTCL) with the Novel HDAC Inhibitor, Belinostat, in Combination with CHOP: Results of the Bel-CHOP Phase 1 Trial

Patrick B. Johnston, MD PhD, Amanda F. Cashen, MD, Petros G. Nikolinakos, MD, Anne W Beaven, MD, Stefan Klaus Barta, MDMRCP,MS, Gajanan Bhat, PhD, Tao Song, Mi Rim Choi, MD, Lee F. Allen, MD PhD, Sven de Vos, MD PhD, Yasuhiro Oki, MD, Changchun Deng, MDPhD, Francine M Foss, MD
Journal: Blood
Blood (2015) 126 (23): 253.
https://doi.org/10.1182/blood.V126.23.253.253
Published: 2015
Journal Articles

Chemical Genomics Reveals JAK STAT Activation As a Mechanism of Resistance to HDAC Inhibitors in B Cell Lymphomas

Matthew S. McKinney, MD, Anne W Beaven, MD, Andrea Moffitt, Jason Landon Smith, MD, Eric Lock, PhD, Dereje Jima, Jane Healy, MD PhD, Guojie Li, Adrienne Greenough, PhD, Cassandra L Love, MS, Xiao Yi Yang, MD, David Dunson, PhD, Herbert Kim Lyerly, MD, Leon Bernal-Mizrachi, MD, Randy D. Gascoyne, MD, Sandeep S. Dave, MD
Journal: Blood
Blood (2014) 124 (21): 271.
https://doi.org/10.1182/blood.V124.21.271.271
Published: 2014
Journal Articles

Short Course of Bendamustine and Rituximab Followed By 90Y-Ibritumomab Tiuxetan in Patients with Chemotherapy-Naïve Follicular Lymphoma: Results of Fol-Brite

Frederick Lansigan, MD, Bassem I Zaki, MD, Stephanie P Yen, MD, Eric S Winer, MD, Helen Ryan, MD, Darcie L Findley, Sara R Metzler, RN, Lynn Shaw, RN, Annie Tsui, RN, Todd MacKenzie, PhD, Anne W Beaven, MD
Journal: Blood
Blood (2014) 124 (21): 1733.
https://doi.org/10.1182/blood.V124.21.1733.1733
Published: 2014